Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
- PMID: 2825031
- DOI: 10.1038/330566a0
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
Abstract
Gs and Gi are guanine nucleotide-binding, heterotrimer proteins that regulate the activity of adenylate cyclase, and are responsible for transferring stimulatory and inhibitory hormonal signals, respectively, from cell surface receptors to the enzyme catalytic unit. These proteins can be directly activated by agents such as GTP and analogues, fluoride and magnesium. Decreased amounts of Gs and Gi, and even the absence of Gs, have been described, whereas an altered Gs has been reported in a cultured cell line (UNC variant of S49 lymphoma cells), but has never been observed in human disease states. We have found a profoundly altered Gs protein in a group of human growth hormone-secreting pituitary adenomas, characterized by high secretory activity and intracellular cyclic AMP levels. In the membranes from these tumours no stimulation of adenylate cyclase activity by growth hormone-releasing hormone, by GTP or by fluoride was observed. Indeed, the last two agents caused an inhibition, probably mediated by Gi. In contrast, adenylate cyclase stimulation by Mg2+ was enormously increased. This altered pattern of adenylate cyclase regulation was reproduced when a cholate extract of the tumour membranes (which contains G proteins) was reconstituted with Gs-free, cyc- S49 cell membranes. Inasmuch as secretion from somatotrophic cells is known to be a cAMP-dependent function, the alteration of Gs could be the direct cause of the high secretory activity of the tumours in which it occurs.
Similar articles
-
The role of GRH mediated AC-cAMP system in the pathogenesis of human pituitary GH-secreting adenomas.Chin Med J (Engl). 1996 Aug;109(8):603-8. Chin Med J (Engl). 1996. PMID: 9206060
-
The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.Mol Pharmacol. 1988 Dec;34(6):761-8. Mol Pharmacol. 1988. PMID: 2849044
-
Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.Mol Pharmacol. 1994 Mar;45(3):380-9. Mol Pharmacol. 1994. PMID: 8145725
-
Signalling pathway alterations in pituitary adenomas: involvement of Gsalpha, cAMP and mitogen-activated protein kinases.J Neuroendocrinol. 2009 Nov;21(11):869-77. doi: 10.1111/j.1365-2826.2009.01910.x. Epub 2009 Sep 1. J Neuroendocrinol. 2009. PMID: 19732293 Review.
-
GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.Biochem Soc Symp. 1990;56:165-70. Biochem Soc Symp. 1990. PMID: 2124121 Review.
Cited by
-
Recurrent gain-of-function USP8 mutations in Cushing's disease.Cell Res. 2015 Mar;25(3):306-17. doi: 10.1038/cr.2015.20. Epub 2015 Feb 13. Cell Res. 2015. PMID: 25675982 Free PMC article.
-
Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern.Front Oncol. 2024 Jul 30;14:1423606. doi: 10.3389/fonc.2024.1423606. eCollection 2024. Front Oncol. 2024. PMID: 39139281 Free PMC article.
-
The Clinicopathological Spectrum of Acromegaly.J Clin Med. 2019 Nov 13;8(11):1962. doi: 10.3390/jcm8111962. J Clin Med. 2019. PMID: 31766255 Free PMC article. Review.
-
G protein mutations in pituitary tumors: a study on Turkish patients.Pituitary. 2003 Sep;6(2):75-80. doi: 10.1023/b:pitu.0000004797.89592.5e. Pituitary. 2003. PMID: 14703016
-
The curious case of Gαs gain-of-function in neoplasia.BMC Cancer. 2018 Mar 15;18(1):293. doi: 10.1186/s12885-018-4133-z. BMC Cancer. 2018. PMID: 29544460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical